Quantcast

Latest Genelux Corporation Stories

2013-07-19 23:01:51

Jamie Reno, an award-winning journalist, cancer survivor and patient advocate, discussed on his blog in depth recent discoveries by a small biotech firm in San Diego that has made significant

2011-08-04 14:16:00

SAN DIEGO, Aug. 4, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr. Catherine J.

2011-01-24 11:00:00

SAN DIEGO, Jan. 24, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr.

2011-01-12 06:00:00

SAN DIEGO, Jan. 12, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, San Diego-based biopharmaceutical company developing novel therapies against cancer, today announced that its Board of Directors has appointed Jodi Devlin as the company's President effective January 10, 2011. Dr.

2007-11-12 21:00:07

SAN DIEGO, Nov. 12 /PRNewswire/ -- In its Oct. 15 issue, Cancer Research, published a peer-reviewed article from Genelux Corporation describing successful eradication of human breast cancer tumors in animals using GL-ONC1, a novel oncolytic virus developed by Genelux scientists.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related